Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ (2013)

  • Authors:
  • USP affiliated authors: CHAMMAS, ROGER - FM
  • USP Schools: FM
  • DOI: 10.1007/s00795-013-0013-4
  • Subjects: NEOPLASIAS MAMÁRIAS; IMUNOHISTOQUÍMICA; CARCINOMA DE DUCTOS INFILTRANTE; SEGUIMENTOS; PROGNÓSTICO; LECTINAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00795-013-0013-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s00795-013-0013-4 (Fonte: Unpaywall API)

    Título do periódico: Medical Molecular Morphology

    ISSN: 1860-1480,1860-1499



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Brain Research

    ISSN: 0006-8993

    Citescore - 2017: 3.02

    SJR - 2017: 1.404

    SNIP - 2017: 0.828


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2391808-10BCSEP 260 2013
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RÊGO, Moacyr Jesus Barreto de Melo; MELLO, Gabriela Souto Vieira de; SANTOS, Carlos André da Silva; CHAMMAS, Roger; BELTRÃO, Eduardo Isidoro Carneiro. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ. Medical molecular morphology, Tokyo, v. 46, n. 2, p. 92-96, 2013. Disponível em: < http://link.springer.com/content/pdf/10.1007%2Fs00795-013-0013-4.pdf > DOI: 10.1007/s00795-013-0013-4.
    • APA

      Rêgo, M. J. B. de M., Mello, G. S. V. de, Santos, C. A. da S., Chammas, R., & Beltrão, E. I. C. (2013). Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ. Medical molecular morphology, 46( 2), 92-96. doi:10.1007/s00795-013-0013-4
    • NLM

      Rêgo MJB de M, Mello GSV de, Santos CA da S, Chammas R, Beltrão EIC. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ [Internet]. Medical molecular morphology. 2013 ; 46( 2): 92-96.Available from: http://link.springer.com/content/pdf/10.1007%2Fs00795-013-0013-4.pdf
    • Vancouver

      Rêgo MJB de M, Mello GSV de, Santos CA da S, Chammas R, Beltrão EIC. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ [Internet]. Medical molecular morphology. 2013 ; 46( 2): 92-96.Available from: http://link.springer.com/content/pdf/10.1007%2Fs00795-013-0013-4.pdf

    Referências citadas na obra
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancerbase No. 10 [Internet]. International Agency for Research on Cancer, Lyon
    Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554
    Ruan K, Song G, Ouyang G (2009) Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107(6):1053–1062
    Bussolati G, Bongiovanni M, Cassoni P, Sapino A (2000) Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification. Virchows Arch 437(4):360–364
    Cosse JP, Michiels C (2008) Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 8:790–797
    Moeller BJ, Richardson RA, Dewhirst MW (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26:241–248
    Shirato K, Nakajima K, Korekane H, Takamatsu S, Gao C, Angata T, Ohtsubo K, Taniguchi N (2011) Hypoxic regulation of glycosylation via the N acetylglucosamine cycle. J Clin Biochem Nutr 48(1):20–25
    TaniguchI N (2009) From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises. J Biol Chem 284(50):34469–34478
    Vasta GR (2012) Galectins as pattern recognition receptors: structure, function and evolution. Adv Exp Med Biol 946:21–36
    Ghazarian H, Idoni B, Oppenheimer SB (2011) A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 113:236–254
    Olbryt M, Jarzab M, Jazowiecka-rakus J, Simek K, Szala S, Sochanik A (2006) Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro. Gene Expr 13(3):191–203
    Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O’Byrne KJ, Giaccia AJ, Koong AC (2005) Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23(35):8932–8941
    Goetz JA, Mechref Y, Kang P, Jeng MH, Novotny MV (2009) Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J 26:117–131
    Powlesland AS, Hitchen PG, Parry S, Graham SA, Barrio MM, Elola MT, Mordoh J, Dell A, Drickamer K, Taylor ME (2009) Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiol 19:899–909
    Ono M, Hakomori S (2004) Glycosylation defining cancer cell motility and invasiveness. Glycoconj J 20:71–78
    Shimma Y, Jigami Y (2004) Expression of human glycosyltransferase genes in yeast as a toll for enzimatic synthesis of sugar chain. Glycoconj J 21:75–78
    Shinji G, Chihiro S, Jun Y, Reiji K, Ken K (2007) Hypoxia-enhanced expression of free deaminoneuraminic acid in human cancer cells. Biochem Biophys Res Commun 357(2):7537–7542
    Koike T, Kimura N, MIyazaki K, Yabuta T, Kumamoto K, Takenoshita S, Chen J et al (2004) Hypoxia induces adhesion molecules on cancer cells: a missing link between warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA 101(21):8132–8137
    Suzuki O, Nozawa Y, Kawaguchi T, Abe M (2003) Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-Acetyl-glucosaminyl transferase V in human diffuse large B cell lymphoma. Oncol Rep 10(6):1759–1764
    Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen GY, Takematsu H, Kozutsumi Y, Suzuki A, Furuhata K, Cheng FL, Lin CH, Sato C, Kitajima K, Kannagi R (2006) Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 66(6):2937–2945
    Varki A, Kannagi R, Toole BP (2009) Changes in glycosylation Cancer. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology. Cold Spring Harbor Laboratory Press, New York. http://www.ncbi.nlm.nih.gov/books/NBK1963/
    Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, Lee YJ, Hong SC, Choi SK, Ha WS, Kim JW, Lee CW, Lee JS, Park ST (2007) Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120(11):2331–2338
    Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57(23):5272–5276